Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats inflammation and pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain. GNH USA supplies Movalis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves function in patients with degenerative joint disease. - Rheumatoid arthritis: decreases inflammatory activity and joint swelling in chronic autoimmune arthritis. - Ankylosing spondylitis: relieves spinal stiffness and pain in inflammatory axial spondyloarthritis. - Acute pain: provides rapid analgesia for short‑term severe pain episodes.

Common side effects are generally mild and reversible.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia) - Headache - Dizziness - Peripheral edema - Elevated blood pressure - Skin rash

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular events such as myocardial infarction - Hepatic enzyme elevation or hepatitis - Severe skin reactions (Stevens‑Johnson syndrome) - Renal impairment or failure - Anaphylactic reactions

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Cardiovascular risk assessment: evaluate history of heart disease before use. - Gastrointestinal monitoring: watch for signs of ulcer or bleeding, especially in high‑risk patients. - Renal and hepatic function: check baseline labs and adjust if impairment is present. - Elderly patients: use the lowest effective dose and monitor for adverse events. - Hypersensitivity: avoid in individuals with known allergy to meloxicam or other NSAIDs. - Store at below 25°C: keep in the original pack, protect from moisture.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding potential. - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: increased lithium serum levels.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced renal perfusion. - Corticosteroids: additive risk of gastrointestinal ulceration. - Methotrexate: possible increased toxicity. - Cyclosporine: enhanced nephrotoxic effect. - Antihypertensives: may blunt blood pressure control.